| Patent | Date |
|---|
Solid forms of a GlyT1 inhibitor
Grant 11,447,474 - Gao , et al. September 20, 2 | 2022-09-20 |
Polymorphs
App 20210323964 - SIEGER; Peter ; et al. | 2021-10-21 |
Polymorphs
Grant 11,084,819 - Sieger , et al. August 10, 2 | 2021-08-10 |
Solid Forms of a GlyT1 Inhibitor
App 20200347041 - GAO; Joe Ju ; et al. | 2020-11-05 |
Administration Of Ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- L-1h-benzimidazol-5-carbonyl)
App 20200085807 - BRAUNS; Ulrich ; et al. | 2020-03-19 |
Polymorphs
App 20200055856 - SIEGER; Peter ; et al. | 2020-02-20 |
Administration Of Ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- L-1h-benzimidazol-5-carbonyl)
App 20190231766 - BRAUNS; Ulrich ; et al. | 2019-08-01 |
Polymorphs
App 20190233423 - SIEGER; Peter ; et al. | 2019-08-01 |
Polymorphs
Grant 10,301,313 - Sieger , et al. | 2019-05-28 |
Administration Of Ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- L-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionate
App 20180221359 - BRAUNS; Ulrich ; et al. | 2018-08-09 |
Polymorphs
App 20180099969 - SIEGER; Peter ; et al. | 2018-04-12 |
Polymorphs
Grant 9,815,837 - Sieger , et al. November 14, 2 | 2017-11-14 |
Polymorphs
App 20170022203 - SIEGER; Peter ; et al. | 2017-01-26 |
Polymorphs
Grant 9,493,462 - Sieger , et al. November 15, 2 | 2016-11-15 |
Device, System Having Such Devices, Method For Implementing The System And Computer Program Product For Implementing The Method
App 20160224307 - Sieger; Peter | 2016-08-04 |
Polymorphs
App 20160122352 - SIEGER; Peter ; et al. | 2016-05-05 |
Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-di- aza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof
Grant 9,309,228 - Ostermeier , et al. April 12, 2 | 2016-04-12 |
Polymorphs
Grant 9,266,888 - Sieger , et al. February 23, 2 | 2016-02-23 |
Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-a- mino-piperidin-1-yl)-xanthine
Grant 9,212,183 - Sieger , et al. December 15, 2 | 2015-12-15 |
9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-di- Aza-spiro[5.5]undecane-5-one Dimaleate, Use Thereof As A Medicament And Method For The Production Thereof
App 20140371226 - PFRENGLE; Waldemar ; et al. | 2014-12-18 |
9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-dia- za-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
Grant 8,906,931 - Pfrengle , et al. December 9, 2 | 2014-12-09 |
Polymorphs
App 20140357646 - SIEGER; Peter ; et al. | 2014-12-04 |
Process For Preparing New Tiotropium Salts, New Tiotropium Salts As Such And Pharmaceutical Compositions Thereof
App 20140316138 - POP; Mihaela Maria ; et al. | 2014-10-23 |
Salt forms of a xanthine compound
Grant 8,865,729 - Sieger , et al. October 21, 2 | 2014-10-21 |
Salt Forms Of Organic Compound
App 20140303194 - SIEGER; Peter ; et al. | 2014-10-09 |
9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-di- aza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
Grant 8,853,225 - Pfrengle , et al. October 7, 2 | 2014-10-07 |
Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
Grant 8,686,148 - Banholzer , et al. April 1, 2 | 2014-04-01 |
Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
Grant 8,664,222 - Linz , et al. March 4, 2 | 2014-03-04 |
8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
Grant 8,637,530 - Pfrengle , et al. January 28, 2 | 2014-01-28 |
Fumaric Acid Salt Of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-di- Aza-spiro[5.5]undecan-5-one, Its Use As A Medicament And The Preparation Thereof
App 20140024628 - OSTERMEIER; Markus ; et al. | 2014-01-23 |
Crystalline forms of a hexahydrofuro[3,4-c]quinoline derivative
App 20130210851 - OSTERMEIER; Markus ; et al. | 2013-08-15 |
Process for preparing amino crotonyl compounds
Grant 8,426,586 - Soyka , et al. April 23, 2 | 2013-04-23 |
9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-di- Aza-spiro[5.5]undecane-5-one Dimaleate, Use Thereof As A Medicament And Method For The Production Thereof
App 20130030003 - PFRENGLE; Waldermar ; et al. | 2013-01-31 |
Process For The Synthesis Of Derivatives Of 3-amino-tetrahydrofuran-3-carboxylic Acid And Use Thereof As Medicaments
App 20130005962 - HAN; Zhengxu ; et al. | 2013-01-03 |
Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-et- hyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino- ]-3-methoxy-benzamide
Grant 8,329,695 - Linz , et al. December 11, 2 | 2012-12-11 |
Polymorphs
App 20120296091 - SIEGER; Peter ; et al. | 2012-11-22 |
Specific Salt, Anhydrous And Crystalline Form Of A Dihydropteridione Derivative
App 20120214995 - Linz; Guenter ; et al. | 2012-08-23 |
Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide
Grant 8,202,867 - Linz , et al. June 19, 2 | 2012-06-19 |
8-(3-amino-piperidin-1-yl)-xanthines, Their Preparation, And Their Use As Pharmaceuticals
App 20120142712 - PFRENGLE; Waldemar ; et al. | 2012-06-07 |
Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
Grant 8,188,086 - Linz , et al. May 29, 2 | 2012-05-29 |
Salt Forms Of Organic Compound
App 20120129874 - Sieger; Peter ; et al. | 2012-05-24 |
Salts and hydrates of 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(cis-4--cyclohexan-1-yloxy)-7-metho- xy-quinazoline, their use as a medicament and the preparation thereof
App 20120046284 - EGEN; Marc ; et al. | 2012-02-23 |
8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
Grant 8,106,060 - Pfrengle , et al. January 31, 2 | 2012-01-31 |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
Grant 8,034,809 - Lustenberger , et al. October 11, 2 | 2011-10-11 |
Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
Grant 8,034,816 - Linz , et al. October 11, 2 | 2011-10-11 |
Crystalline anhydrate with anticholinergic efficacy
Grant 7,968,717 - Pfrengle , et al. June 28, 2 | 2011-06-28 |
Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof
Grant 7,939,658 - Ries , et al. May 10, 2 | 2011-05-10 |
3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino- ]propionic acid ethylester methansulfonate and its use as a medicament
Grant 7,932,273 - Schmid , et al. April 26, 2 | 2011-04-26 |
Crystalline Hydrate Of Betamimetika And Use As Medicament Thereof
App 20100331288 - Aven; Michael ; et al. | 2010-12-30 |
Process For The Synthesis Of Derivatives Of 3-amino-tetrahydrofuran-3-carboxylic Acid And Use Thereof As Medicaments
App 20100317848 - Han; Zhengxu ; et al. | 2010-12-16 |
Crystalline Form Of A Dihydropteridione Derivative
App 20100280037 - Linz; Guenter ; et al. | 2010-11-04 |
Single Enantiomer Beta-agonists, Methods For The Production Thereof And The Use Thereof As Medication
App 20100222336 - Konetzki; Ingo ; et al. | 2010-09-02 |
Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridi- nyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
Grant 7,728,134 - Linz , et al. June 1, 2 | 2010-06-01 |
Enantiomerically pure beta agonists, manufacturing and use thereof
Grant 7,709,474 - Konetzki , et al. May 4, 2 | 2010-05-04 |
Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
App 20100087488 - Pop; Mihaela ; et al. | 2010-04-08 |
New Salts and Crystalline Salt Forms of an Indolinone Derivative
App 20090318471 - Sieger; Peter ; et al. | 2009-12-24 |
Methods of Using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide
App 20090318457 - LINZ; Guenter ; et al. | 2009-12-24 |
Novel Enantiomeric Pure Beta Agonists, Manufacturing And Use As A Medicaments Thereof
App 20090306068 - RIES; Uwe ; et al. | 2009-12-10 |
Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
App 20090298840 - LINZ; Guenter ; et al. | 2009-12-03 |
Enantiomerically Pure Beta Agonists, Process For The Manufacture Thereof And Use Thereof As Medicaments
App 20090137578 - LUSTENBERGER; Philipp ; et al. | 2009-05-28 |
Enantiomeric pure .beta. agonists, manufacturing and use as a medicament thereof
Grant 7,534,789 - Ries , et al. May 19, 2 | 2009-05-19 |
Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
Grant 7,514,468 - Heckel , et al. April 7, 2 | 2009-04-07 |
Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
Grant 7,491,719 - Lustenberger , et al. February 17, 2 | 2009-02-17 |
Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
App 20090042948 - Sieger; Peter ; et al. | 2009-02-12 |
Specific Salt, Anhydrous And Crystalline Form Of A Dihydropteridione Derivative
App 20090030004 - Linz; Guenter ; et al. | 2009-01-29 |
Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
Grant 7,439,358 - Linz , et al. October 21, 2 | 2008-10-21 |
Benzoylguanidine Salt And Hydrates Thereof
App 20080241077 - Eickmeier; Christian ; et al. | 2008-10-02 |
3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) Phenylamino]methyl}-1-methyl-1h-benzimidazol-5- Carbonyl)pyridin-2-ylamino]propionic Acid Ethylester Methansulfonate And Its Use As A Medicament
App 20080119523 - Schmid; Rolf ; et al. | 2008-05-22 |
(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
App 20080076934 - Linz; Guenter ; et al. | 2008-03-27 |
Enantiomerically Pure Beta Agonists, Manufacturing And Use Thereof
App 20080070909 - KONETZKI; Ingo ; et al. | 2008-03-20 |
Benzoylguanidine Salt And Hydrates Thereof
App 20080025919 - Eickmeier; Christian ; et al. | 2008-01-31 |
(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(py- rrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
Grant 7,294,721 - Linz , et al. November 13, 2 | 2007-11-13 |
Polymorphs
App 20070259900 - SIEGER; Peter ; et al. | 2007-11-08 |
Novel Enantiomeric Pure Beta Agonists, Manufacturing and Use as a Medicament Thereof
App 20070249595 - RIES; Uwe ; et al. | 2007-10-25 |
Specific Salt, Anhydrous And Crystalline Form Of A Dihydropteridione Derivative
App 20070203146 - Linz; Guenter ; et al. | 2007-08-30 |
Benzoylguanidlne salt and hydrates thereof
App 20070135446 - Elckmeier; Christian ; et al. | 2007-06-14 |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
Grant 7,220,742 - Lustenberger , et al. May 22, 2 | 2007-05-22 |
(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(py- rrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
App 20070099974 - Linz; Guenter ; et al. | 2007-05-03 |
Process for preparing amino crotonyl compounds
App 20070027170 - Soyka; Rainer ; et al. | 2007-02-01 |
8-(3-amino-piperidin-1-yl)-xanthines, Their Preparation, And Their Use As Pharmaceuticals
App 20070027168 - Pfrengle; Waldemar ; et al. | 2007-02-01 |
New enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
App 20070027148 - Lustenberger; Philipp ; et al. | 2007-02-01 |
(R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
Grant 7,169,934 - Linz , et al. January 30, 2 | 2007-01-30 |
Process For Preparing New Tiotropium Salts, New Tiotropium Salts As Such and Pharmaceutical Compositions Thereof
App 20060287530 - Pop; Mihaela Maria ; et al. | 2006-12-21 |
Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-met- hyl-1H- benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
App 20060276513 - HAUEL; Norbert ; et al. | 2006-12-07 |
3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-an- ilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulpho- nate and the use thereof as a pharmaceutical composition
App 20060258681 - Roth; Gerald J. ; et al. | 2006-11-16 |
Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-met- hyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
App 20060247278 - Sieger; Peter ; et al. | 2006-11-02 |
3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-an- ilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulpho- nate and the use thereof as a pharmaceutical composition
Grant 7,119,093 - Roth , et al. October 10, 2 | 2006-10-10 |
Benzoylguanidine salt and hydrates thereof
App 20060217396 - Eickmeier; Christian ; et al. | 2006-09-28 |
Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
App 20060194813 - Heckel; Armin ; et al. | 2006-08-31 |
Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
App 20060035902 - Linz; Guenter ; et al. | 2006-02-16 |
New enentiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
App 20050267106 - Lustenberger, Philipp ; et al. | 2005-12-01 |
3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1- H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as medicament
App 20050234104 - Schmid, Rolf ; et al. | 2005-10-20 |
Novel crystalline anhydrate with anticholinergic efficacy
App 20050143410 - Pfrengle, Waldemar ; et al. | 2005-06-30 |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
Grant 6,908,928 - Banholzer , et al. June 21, 2 | 2005-06-21 |
Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
App 20050131007 - Banholzer, Rolf ; et al. | 2005-06-16 |
Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof
App 20050096341 - Banholzer, Rolf ; et al. | 2005-05-05 |
Process for preparing amino crotonyl compounds
App 20050085495 - Soyka, Rainer ; et al. | 2005-04-21 |
Meloxicam for oral administration
Grant 6,869,948 - Bock , et al. March 22, 2 | 2005-03-22 |
Benzoylguanidine salt and hydrates thereof
App 20050043320 - Eickmeier, Christian ; et al. | 2005-02-24 |
Powder formulations containing tiotropium suitable for inhalation
App 20050009857 - Banholzer, Rolf ; et al. | 2005-01-13 |
3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-an- ilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulpho- nate and the use thereof as a pharmaceutical composition
App 20040176392 - Roth, Gerald J. ; et al. | 2004-09-09 |
Crystalline acetic acid solvate of meloxicam
App 20040171611 - Trummlitz, Guenter ; et al. | 2004-09-02 |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
Grant 6,777,423 - Banholzer , et al. August 17, 2 | 2004-08-17 |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
App 20040152720 - Hartig, Mareke ; et al. | 2004-08-05 |
Benzoylguanidine salt and hydrates thereof
App 20040122019 - Eickmeier, Christian ; et al. | 2004-06-24 |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
App 20040087793 - Banholzer, Rolf ; et al. | 2004-05-06 |
Benzoylguanidine salt and hydrates thereof
Grant 6,730,678 - Eickmeier , et al. May 4, 2 | 2004-05-04 |
Powder formulations containing tiotropium suitable for inhalation
App 20040029907 - Banholzer, Rolf ; et al. | 2004-02-12 |
(R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
App 20040010026 - Linz, Guenter ; et al. | 2004-01-15 |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
App 20030171586 - Banholzer, Rolf ; et al. | 2003-09-11 |
Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
Grant 6,608,055 - Sieger , et al. August 19, 2 | 2003-08-19 |
Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
App 20030087927 - Sieger, Peter ; et al. | 2003-05-08 |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
App 20020169321 - Banholzer, Rolf ; et al. | 2002-11-14 |
| 